Amy Cha

1.6k total citations
37 papers, 673 citations indexed

About

Amy Cha is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Amy Cha has authored 37 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Dermatology, 25 papers in Immunology and Allergy and 11 papers in Physiology. Recurrent topics in Amy Cha's work include Dermatology and Skin Diseases (26 papers), Allergic Rhinitis and Sensitization (21 papers) and Food Allergy and Anaphylaxis Research (11 papers). Amy Cha is often cited by papers focused on Dermatology and Skin Diseases (26 papers), Allergic Rhinitis and Sensitization (21 papers) and Food Allergy and Anaphylaxis Research (11 papers). Amy Cha collaborates with scholars based in United States, United Kingdom and Denmark. Amy Cha's co-authors include Donald Küfe, Helena J. Mauceri, M. Eileen Dolan, Steven J. Chmura, R.R. Weichselbaum, Robin Cohen, Robin Cohen, Bonnie Vlahos, Dale A. Rose and Alexandra M. Oster and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PEDIATRICS.

In The Last Decade

Amy Cha

31 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Cha United States 11 283 207 115 88 76 37 673
Chandler W. Rundle United States 12 198 0.7× 66 0.3× 47 0.4× 16 0.2× 31 0.4× 51 545
Claire Jenkinson United Kingdom 17 205 0.7× 97 0.5× 122 1.1× 61 0.7× 75 1.0× 17 906
David J Margolis United States 5 394 1.4× 103 0.5× 106 0.9× 45 0.5× 24 0.3× 7 830
Adrian Casillas United States 12 56 0.2× 93 0.4× 117 1.0× 98 1.1× 23 0.3× 25 627
Nima Fattahi Iran 16 58 0.2× 8 0.0× 59 0.5× 47 0.5× 90 1.2× 36 650
Tara Rolstad United States 8 1.2k 4.1× 71 0.3× 127 1.1× 211 2.4× 146 1.9× 9 2.5k
R. Rashmi India 9 159 0.6× 14 0.1× 48 0.4× 31 0.4× 38 0.5× 11 526
S. Jay Smith United States 7 220 0.8× 31 0.1× 51 0.4× 52 0.6× 43 0.6× 7 784
Chuin Ying Ung United Kingdom 9 78 0.3× 29 0.1× 58 0.5× 32 0.4× 78 1.0× 16 353
Hye-Jin Shin South Korea 11 19 0.1× 5 0.0× 160 1.4× 39 0.4× 46 0.6× 12 967

Countries citing papers authored by Amy Cha

Since Specialization
Citations

This map shows the geographic impact of Amy Cha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Cha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Cha more than expected).

Fields of papers citing papers by Amy Cha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Cha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Cha. The network helps show where Amy Cha may publish in the future.

Co-authorship network of co-authors of Amy Cha

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Cha. A scholar is included among the top collaborators of Amy Cha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Cha. Amy Cha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eichenfield, Lawrence F., Linda Stein Gold, Charles Lynde, et al.. (2024). Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis. Dermatology and Therapy. 14(4). 875–892.
2.
Feldman, Steven R., Wai Ming Chan, Alfred Ammoury, et al.. (2024). Patients’ and caregivers’ perspectives of the atopic dermatitis journey. Journal of Dermatological Treatment. 35(1). 2315145–2315145. 2 indexed citations
3.
Danby, Simon G., Stephen J. Matcher, Kirsty Brown, et al.. (2024). Novel biophysical skin biomarkers discriminate topical anti‐inflammatory treatments based on their potential for local adverse effects. SHILAP Revista de lepidopterología. 4(1). 103–116.
4.
Goldstein, Nathaniel B., Dennis R. Roop, Yonghua Zhuang, et al.. (2024). Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model. Journal of Investigative Dermatology. 145(4). 883–896. 1 indexed citations
5.
Kobyletzki, Laura von, Dan Henrohn, Natalia Ballardini, et al.. (2023). Comorbidities in childhood atopic dermatitis: A population‐based study. Journal of the European Academy of Dermatology and Venereology. 38(2). 354–364. 8 indexed citations
6.
Lebwohl, Mark, Robert S. Kirsner, David J. Margolis, et al.. (2023). Stasis dermatitis: A challenging patient journey. SHILAP Revista de lepidopterología. 2(4). 675–688. 1 indexed citations
7.
Yosipovitch, Gil, Brian Kim, Thomas A. Luger, et al.. (2023). Similarities and differences in peripheral itch and pain pathways in atopic dermatitis. Journal of Allergy and Clinical Immunology. 153(4). 904–912. 16 indexed citations
8.
Yosipovitch, Gil, et al.. (2023). Stasis Dermatitis: The Burden of Disease, Diagnosis, and Treatment. Dermatitis. 35(4). 337–344. 4 indexed citations
9.
Yosipovitch, Gil, et al.. (2023). Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management. American Journal of Clinical Dermatology. 24(2). 275–286. 20 indexed citations
10.
Danby, Simon G., Amy Cha, Chuanbo Zang, et al.. (2023). Potential application of PS-OCT in the safety assessment of non-steroidal topical creams for atopic dermatitis treatment. Biomedical Optics Express. 14(8). 4126–4126. 7 indexed citations
11.
Duca, Ester Del, Paola Facheris, Yeriel Estrada, et al.. (2023). Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin. Journal of the American Academy of Dermatology. 89(2). 283–292. 7 indexed citations
12.
Kobyletzki, Laura von, Natalia Ballardini, Dan Henrohn, et al.. (2022). Care pathways in atopic dermatitis: a retrospective population‐based cohort study. Journal of the European Academy of Dermatology and Venereology. 36(9). 1456–1466. 9 indexed citations
13.
Ortsäter, Gustaf, Jacob P. Thyssen, Laura B. von Kobyletzki, et al.. (2022). Societal economic burden and determinants of costs for atopic dermatitis. SHILAP Revista de lepidopterología. 1(4). 326–343.
14.
Ortsäter, Gustaf, Jacob P. Thyssen, Laura von Kobyletzki, et al.. (2022). Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases. Dermatology and Therapy. 12(2). 545–559. 6 indexed citations
15.
16.
Eichenfield, Lawrence F., et al.. (2022). Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting. Pediatric Drugs. 24(4). 293–305. 53 indexed citations
17.
Thom, Howard, Hung‐Yuan Cheng, Edna Keeney, et al.. (2021). Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis. Dermatology and Therapy. 12(1). 185–194. 6 indexed citations
18.
Thyssen, Jacob P., Chuanbo Zang, Maureen P. Neary, et al.. (2021). Translating the Investigator’s Static Global Assessment to the Eczema Area and Severity Index in Studies of Crisaborole for Atopic Dermatitis. Dermatology and Therapy. 11(3). 845–853. 4 indexed citations
19.
Danby, Simon G., Zoé Kececioglu Draelos, Linda Stein Gold, et al.. (2020). Vehicles for atopic dermatitis therapies: more than just a placebo. Journal of Dermatological Treatment. 33(2). 685–698. 36 indexed citations
20.
Schlessinger, Joel, Richard Gower, John Su, et al.. (2020). Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1). American Journal of Clinical Dermatology. 21(2). 275–284. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026